These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17983944)

  • 1. The role of integrated positron emission tomography-computerized tomography in evaluating and staging patients with non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Semin Thorac Cardiovasc Surg; 2007; 19(3):192-200. PubMed ID: 17983944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
    Truong MT; Munden RF; Movsas B
    J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
    Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
    Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging lung cancer.
    Patz EF
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):21-6. PubMed ID: 10566607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of VATS for staging and diagnosis in patients with non-small cell lung cancer.
    Howington JA
    Semin Thorac Cardiovasc Surg; 2007; 19(3):212-6. PubMed ID: 17983947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with true pathologic stage I non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT, positron emission tomography, and MRI in staging lung cancer.
    Erasmus JJ; Sabloff BS
    Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer staging.
    Sihoe AD; Yim AP
    J Surg Res; 2004 Mar; 117(1):92-106. PubMed ID: 15013719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study.
    Cerfolio RJ; Bryant AS
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):261-8. PubMed ID: 18242247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do lung cancer specialists follow their patients with stage III non-small cell lung cancer (NSCLC) after definitive treatment? A short report.
    Yumuk PF; Mohammed N; Maat AP; Fink C; Marchal B; O'Brien ME
    Eur J Cancer; 2012 Sep; 48(14):2163-5. PubMed ID: 22633748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
    Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
    Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer.
    Bosmans G; van Baardwijk A; Dekker A; Ollers M; Wanders S; Boersma L; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):139-44. PubMed ID: 17996384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of non-small-cell lung cancer with integrated PET and CT.
    Comans EF
    N Engl J Med; 2003 Sep; 349(12):1188-90; author reply 1188-90. PubMed ID: 14503541
    [No Abstract]   [Full Text] [Related]  

  • 16. Staging of non-small-cell lung cancer with integrated PET and CT.
    Miles KA
    N Engl J Med; 2003 Sep; 349(12):1188-90; author reply 1188-90. PubMed ID: 14503542
    [No Abstract]   [Full Text] [Related]  

  • 17. Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer.
    Kalade AV; Eddie Lau WF; Conron M; Wright GM; Desmond PV; Hicks RJ; Chen R
    Intern Med J; 2008 Nov; 38(11):837-44. PubMed ID: 19120534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer.
    Na II; Lee TH; Choe DH; Cheon GJ; Kim CH; Koh JS; Baek H; Ryoo BY; Yang SH; Lee JC
    Eur J Cancer; 2008 Nov; 44(16):2411-7. PubMed ID: 18707868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
    Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluoro-2-deoxy-D-glucose standardized uptake value in cavitating non-small-cell lung carcinoma.
    Coffey JP; Hill JC
    Nucl Med Commun; 2008 Dec; 29(12):1040-5. PubMed ID: 18987523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.